WASHINGTON -- Billionaire activist investors are joining forces to raid Congress for more power. According to a Wall Street Journal report, hedge fund operators Paul Singer, Carl Icahn, Bill Ackman, Barry Rosenstein and Dan Loeb formed a lobbying trade group called the Council for Investor Rights and Corporate Accountability, or CIRCA. Show More Summary
Pershing Square just posted a first-quarter letter to shareholders running through the hedge fund's investments. The fund, and its founder Bill Ackman, had a torrid start to the year. It seemed almost all of the fund's investment went...Show More Summary
It has been a twofer from Bill Ackman's Pershing Square this afternoon, which first released its latest weekly performance moments ago, revealing that as of May 10 it was down -1.7% for the month, but also -19.4% YTD, back to its worst...Show More Summary
William Doyle is leaving Pershing Square, according to reports. Doyle, who attended Harvard Business School with Pershing founder Bill Ackman, played a key role in Pershing's investment in Valeant. More to follow Join the conversation about this story » NOW WATCH: How one simple mistake cost 'Real Housewives' superstar Bethenny Frankel millions
Bill Ackman (Trades, Portfolio) is said to be preparing to partially withdraw from pet health care company Zoetis (NYSE:ZTS) where he had waged an activist campaign, but first-quarter portfolios rolling in this month already show several other well-known managers have piled in. Anonymous sources told The New York Times and Bloomberg [...]
The acquisitive maker of Botox is devoting capital to buybacks and paying down debt. Meanwhile, Bill Ackman is selling a big stake in the animal-health company he has been pushing as a takeover target. With luck, the two moves together signal a more subdued approach to deals.
The hits just keep on coming.
If you heard that Bill Ackman is selling shares of a health care stock, you might think that he’s finally cutting his losses on Valeant Pharmaceuticals (VRX), a company that’s down more than 70% since the start of the year, plagued by drug pricing mistakes, its delayed (and troubling) 10-K report, and debt situation. Show More Summary
If you're going to talk sh!t about Valeant, just assume that Bill is listening.
The US Senate has released 818 pages of Valeant-related information connected with the investigation into the pharmaceutical company's business practices. Along with a variety of emails and documents, the dump includes a number of messages...Show More Summary
Activist hedge fund manager Bill Ackman has some thoughts on what Valeant should do next. He recently urged the former CEO of Valeant to go public with plans to IPO part of its subsidiary, Bausch & Lomb, and late last year suggestedShow More Summary
The Senate published a bunch of documents pertaining to Valeant on Friday night, and it is a goldmine of info. We're running through the 818-page document and will be pulling out some of the highlights. First up, here is an email from...Show More Summary
By EconMatters Bill Ackman needs a lesson in proper Trade Management for his miscues on managing his Herbalife Short Position. Double Bottom or Head and Shoulders Pattern on HLF Chart? There is still a substantial short interest percentage...Show More Summary
Finance Insider is Business Insider's summary of the top stories of the past 24 hours. The US economy added 160,000 jobs in April, fewer than expected, as the unemployment rate held steady at 5.0%. The good news is that more people are...Show More Summary
Shares of Herbalife are soaring to their highest level in a year after the company hinted at a possible resolvement to its case with the Federal Trade Commission. Herbalife CEO Michael Johnson said that the investigation by the FTC is...Show More Summary
Bill Ackman, asked about Herbalife (HLF) on CNBC the other day, advised employees of the supplement seller to “find another job.” He also said his short position against the company hasn’t changed. So, Ackman likely isn’t feeling great right now since Herbalife’s shares are zooming higher on the heels of a quarterly earnings report that […]